Barriers in utilizing lipid-lowering agents in non-institutionalized population in the U.S.: Application of a theoretical framework
Cardiovascular diseases are a major cause of death globally. Epidemiological evidence has linked elevated levels of blood cholesterol with the risk of coronary heart disease. However, lipid-lowering agents, despite their importance for primary prevention, are significantly underused in the United St...
Main Authors: | Abdullah A. Alfaifi, Leanne Lai, Abdullah U. Althemery |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341603/?tool=EBI |
Similar Items
-
Barriers in utilizing lipid-lowering agents in non-institutionalized population in the U.S.: Application of a theoretical framework.
by: Abdullah A Alfaifi, et al.
Published: (2021-01-01) -
Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008
by: Kuznik Andreas, et al.
Published: (2011-04-01) -
A comparison between warfarin and apixaban: A patient's perspective
by: Abdullah U Althemery, et al.
Published: (2020-01-01) -
Gendered Bodies and the U.S. Military: Exploring the Institutionalized Regulation of Bodies
by: Horton, Heather K
Published: (2014) -
South Korea-U.S. free trade agreement will lower export barriers for California products
by: Hyunok Lee, et al.
Published: (2008-05-01)